HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1896663Generated: October 31, 2026
HCID 57461728, compound → HCID 58235131, compound
https://huagongshe.com/reaction/1896663
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 57461728 | HCID 57461728 | — |
| Reactant | tert-Butyl 4-{5-[2-(methylamino)pyrimidin-4-yl]-4-phenyl-1H-imidazol-1-yl}piperidine-1-carboxylate | HCID 58235109 | — |
| Product | HCID 58235131 | HCID 58235131 | — |
Reaction Steps
The title compound was prepared from tert-butyl 4-{5-[2-(methylamino)pyrimidin-4-yl]-4-phenyl-1H-imidazol-1-yl}piperidine-1-carboxylate (C25) according to the general procedure for the synthesis of 4-(4-phenyl-1-piperidin-4-yl-1H-imidazol-5-yl)pyrimidine (C23) in Example 11. In this case, after the organic layers were dried over magnesium sulfate, filtered, and concentrated under reduced pressure, the product was obtained as a white solid. Yield: 174 mg, 0.520 mmol, 100%. APCI m/z 335.0 (M+1). 1H NMR (400 MHz, CD3OD) δ 2.09-2.20 (m, 2H), 2.37 (br d, J=12 Hz, 2H), 2.97 (s, 3H), 3.0-3.04 (m, 2H), 3.41-3.46 (m, 2H), 4.93 (tt, J=12, 4 Hz, 1H, assumed; partially obscured by water signal), 6.33 (d, J=5.1 Hz, 1H), 7.27-7.35 (m, 3H), 7.37-7.41 (m, 2H), 8.05 (s, 1H), 8.09 (d, J=5.1 Hz, 1H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08518944B2 |
|---|
| Source dataset | uspto-grants-2013_08 |
|---|
| ORD ID | ord-21a4462289a142f3ac1a8dd1d5b5fc78 |
|---|
| Source note | uspto-grants-2013_08 |
|---|